【レポートの概要（一部）】
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Overview of cancer
• Epidemiology
• Economic burden of cancer
PART 06: Biosimilars industry
• Comparison between biosimilars and generic small molecules
• Factors influencing biologics and biosimilars
• Biosimilars: business and pricing strategy
• Factors affecting the uptake of biosimilars
• Biosimilar opportunities
• Growth of biosimilars 2014– 2020
• Market penetration of originators and biosimilars in different regions
• Current and future trends in global oncology biosimilars market
• Challenges for new entrants
PART 07: Global pharmaceutical market
• Market size and forecast
• Global biosimilars market
PART 08: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 09: Market segmentation by end-user
• Hospitals
• Retail pharmacies
PART 10: Market segmentation by application
• Cancer treatment drugs
• Supportive care drugs
PART 11: Geographical segmentation
• Global oncology biosimilar drugs market by geographical segmentation 2015-2020
• Oncology biosimilars market in EMEA
• Oncology biosimilars market in APAC
• Oncology biosimilars market in Americas
PART 12: Key leading regions
• US
• Europe
• Japan
• India
• China
PART 13: Market drivers
• Rise in number of patent expiries
• Increase in prevalence of cancer
• Growing aging population
• Promising drug pipeline
• Need for cost-effective treatment
• Favorable government regulations
PART 14: Impact of drivers
PART 15: Market challenges
• Risks related to failure of drugs in market
• Multiple manufacturing complexities
• Reluctance among physicians to prescribe biosimilar products
• Complicated regulatory process
• Limited availability of biosimilar products
• Risk of side effects
PART 16: Impact of drivers and challenges
PART 17: Market trends
• Emergence of biosimilars
• Outsourcing of biosimilar manufacturing activities
• Rising number of strategic collaborations
• Increase in cancer awareness
• Rise in R&D
PART 18: Vendor landscape
• Competitive scenario
• Biocon
• Celltrion
• Dr. Reddy’s Laboratories
• F Hoffmann-La Roche
• Hospira
• Mylan
• Sandoz
• Other prominent vendors
PART 19: Appendix
• List of abbreviations
PART 20: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Global biosimilars and oncology biosimilars market 2015
Exhibit 03: Cancer burden in European Union (EU)
Exhibit 04: Global incidence of cancer 2015
Exhibit 05: Global mortality of cancer type 2015
Exhibit 06: Estimated numbers of cancer survivors by age in US 2014
Exhibit 07: Definition of biosimilars in different regions
Exhibit 08: Comparison between biosimilars and generic small molecules
Exhibit 09: Factors influencing biologics and biosimilars
Exhibit 10: Impact of biosimilars cost savings on various sectors
Exhibit 11: Factors affecting success of biosimilars
Exhibit 12: Biosimilars industry: Point-of-view
Exhibit 13: Factors affecting the uptake of biosimilars
Exhibit 14: Strategic factors for new entrant
Exhibit 15: Growth of biosimilars
Exhibit 16: Share of biosimilars in recombinant drugs sales in major markets 2014
Exhibit 17: Trends in global oncology biosimilars market
Exhibit 18: Challenges for new entrants
Exhibit 19: Global pharmaceutical market 2015-2020 ($ trillions)
Exhibit 20: Global biosimilars market 2015-2020 ($ billions)
Exhibit 21: Number of approved biosimilars in regulated and semi-regulated markets
Exhibit 22: Global pharmaceutical, biosimilars, and oncology biosimilars market 2015 ($ billions)
Exhibit 23: Global oncology biosimilars market 2015-2020 ($ billions)
Exhibit 24: Global oncology biosimilars market overview
Exhibit 25: Five forces analysis
Exhibit 26: Oncology biosimilars market segmentation by end-user 2014
Exhibit 27: Global oncology biosimilars segmentation by application
Exhibit 28: Oncology biosimilars by application
Exhibit 29: Global oncology biosimilars market by geographical segmentation 2015
Exhibit 30: Global oncology biosimilars market revenue by geography 2015-2020 ($ billions)
Exhibit 31: Oncology biosimilars market in EMEA 2015-2020 ($ billions)
Exhibit 32: Oncology biosimilars market in APAC 2015-2020 ($ billions)
Exhibit 33: Oncology biosimilars market in Americas 2015-2020 ($ billions)
Exhibit 34: Global oncology biosimilars market: YoY revenue and growth based on geography 2015-2020 ($ billions)
Exhibit 35: Key leading regions
Exhibit 36: Pharmaceutical R&D expenditure in US 2010-2015 ($ billions)
Exhibit 37: Approvals of biologicals versus biosimilars via PHSA
Exhibit 38: Approval process for biosimilars in US
Exhibit 39: Benefits of biosimilars to US healthcare system
Exhibit 40: Role of stake holders
Exhibit 41: SWOT analysis
Exhibit 42: Oncology biosimilars approved by EMA in Europe
Exhibit 43: Guidelines for biosimilars in EU
Exhibit 44: Time line of biosimilars in Europe
Exhibit 45: Key stake holders
Exhibit 46: Key drivers and restraints
Exhibit 47: Biosimilar industry challenges in Europe
Exhibit 48: SWOT analysis
Exhibit 49: Biosimilars approved by PMDA in Japan
Exhibit 50: Review process for biosimilars in Japan
Exhibit 51: Drivers and challenges in oncology biosimilars market in Japan
Exhibit 52: SWOT analysis
Exhibit 53: Biosimilars approved in India
Exhibit 54: Timeline for development of biosimilars in India
Exhibit 55: Challenges and strategies
Exhibit 56: Major domestic and international vendors operating in India
Exhibit 57: Drivers and challenges
Exhibit 58: SWOT analysis
Exhibit 59: Top domestic and international vendors operating in China
Exhibit 60: Drivers and challenges
Exhibit 61: SWOT analysis
Exhibit 62: Patent expiries of oncology biologics in US and EU 2020
Exhibit 63: Global incidence of cancer 2015 and 2020
Exhibit 64: Impact of drivers
Exhibit 65: Impact of drivers and challenges
Exhibit 66: Global competitive landscape 2015
Exhibit 67: Biocon: Key takeaways
Exhibit 68: Celltrion: Key takeaways
Exhibit 69: Dr. Reddy’s Laboratories: Key takeaways
Exhibit 70: F. Hoffmann-La: Key takeaways
Exhibit 71: Hospira: Key takeaways
Exhibit 72: Mylan: Key takeaways
Exhibit 73: Sandoz: Key takeaways
【レポート販売概要】
■ タイトル：腫瘍用バイオ後続品の世界市場：がん治療薬、支持療法用薬■ 英文：Global Oncology Biosimilars Market 2016-2020
■ 発行日：2016年2月17日
■ 調査会社：Technavio
■ 商品コード：IRTNTR8749
■ 調査対象地域：グローバル
- 車載エンターテイメントおよび情報システムの世界市場About in-vehicle entertainment and information systems Conventional in-vehicle entertainment systems consisted of radio, cassettes, and CDs. The advances in technology and growing demand for personalized entertainment, navigation, and connectivity have redefined these systems. In-vehicle entertainment and information systems are a combination of software and hardware devices installed in automobil …
- Squamous Non-Small Cell Lung Cancer：グローバル臨床試験動向（2014年上半期）Squamous Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Squamous Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014" provides data on the Squamous Non-Small Cell Lung Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Squamous Non-Small Cell Lung Canc …
- 世界の小売産業における従業員（Workforce）管理ソフト市場動向（2012-2016）TechNavio's analysts forecast the Global Workforce Management Software market in the Retail industry to grow at a CAGR of 5.67 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased demand from Small and Medium-sized Enterprises. The Global Workforce Management Software market in the Retail industry has also been witnessing the emergence of cl …
- レーザー材料の世界市場2018-2022About Laser Materials Lasers are light-emitting devices comprising laser diodes, circuit board, laser cases, and optics. They are used in electrical and electronics industry, and laser materials such as ceramics and metals are extensively used in semiconductor devices. Other laser materials such as glass, plastics, and epoxy-based materials are used in semiconductor devices to encapsulate electron …
- 世界金融危機後の保険市場Timetric’s 'Insight Report: Insurance Markets after the Global Financial Crisis' report analyzes the performance of the global insurance industry while dealing with the impact of the global financial crisis, which had a negative impact on the insurance industry, particularly in developed markets. However, the insurance industry in developed markets has finally managed to emerge from crisis, showin …
- 麻酔深度モニタリングの世界市場予測（～2024年）“Increasing number of surgeries in the US to drive the overall growth of the US depth of anesthesia monitoring market” The US depth of anesthesia monitoring market is projected to grow from USD 141 million in 2018 to USD 170 million by 2024, at a CAGR of 3.2% during the forecast period. The increasing number of surgeries and rising patient volume in hospitals in the US are the major factors drivin …
- ミオクローヌス（Myoclonus）治療のグローバル臨床試験動向（2014年H2）Myoclonus Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Myoclonus Global Clinical Trials Review, H2, 2014" provides data on the Myoclonus clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Myoclonus. It includes an overview of the trial numbers and their recruitment status as per the site of trial c …
- 軟質磁性材料の世界市場：技術、材料、デバイス、開発、産業構造Magnets are important and highly sophisticated engineering materials that play a fundamental role in many of the electrical and electronic systems that serve modern society. Magnets might be divided into two classes – permanent and soft magnetic materials. Permanent magnetic materials are those which are constantly magnetized, while soft magnetic materials exhibit magnetic properties only when sub …
- 情報技術（IT）産業年鑑2015PLUNKETT'S INFOTECH INDUSTRY ALMANAC 2015 Key Findings: • Plunkett Research lists top 500 companies in InfoTech and names top trends changing the industry for the mid term. Key Features: • Industry trends analysis, market data and competitive intelligence • Market forecasts and Industry Statistics • Industry Associations and Professional Societies List • In-Depth Profiles of hundreds of leading co …
- ヨーロッパのCement Clinker市場Cement Clinker: European Union Market Outlook 2012 and Forecast till 2017 provides a complete overview of the market condition. All available data is presented in a comprehensive and easily accessed format. The report provides our Clients with a clear understanding of market current state and future development. Scope The report contains an in-depth analysis of the European Union market for cement …
- アンテナ、変換器及びレードームのグローバル市場動向（2014-2020）This report presents a complete market study of the global antenna, radome and transducer market over the next six years, (2014-2020). It also provides the factors that drive the market, the challenges the market face, and the restraints impacting the growth of the radar market and its industry. It also contains brief information about industry trends, market trends, and technology trends that are …
- 世界の重油市場：主要企業の支出及び生産予測と展望Heavy oil is a poorer quality crude with a higher carbon to hydrogen ratio and more impurities such as sulphur and metals. It is usually found in formations where the cap rock has provided insufficient protection allowing bacteria to enter and degrade the oil over time. Heavy oil in this report is defined as oil with an API gravity of under 22o that is mobile or semi-mobile at reservoir conditions …
- 動物用飼料の世界市場2015-2019About Animal Feed Animal feed refers to food for livestock, such as poultry, swine, cattle, horse, poultry, and sheep. It includes feed cereals, cakes and meals, co-products from food sector, minerals, additives, and vitamins, oil and fats, and supplements, such as silage of legumes, grass, and hay, or harvested crops. The animal feed ideally is high in fiber content, vitamins, minerals, and other …
- RCSの市場機会（Market Opportunity: Rich Communications Suite (RCS)）Rich Communication Services (RCS) originally marketed by GSMA marks the transition of messaging and voice capabilities from Circuit Switched technology to an all-IP world. RCS and Voice over LTE (VoLTE) share the same IP Multimedia Subsystem (IMS) investment and leverage the same IMS capabilities. For consumers, RCS has the potential to combine voice and SMS with instant messaging or chat, live vi …
- 軍用航空シミュレーション及びトレーニングの世界市場2015-2019About Simulation and Training A military flight simulator is used to artificially re-create aircraft flight and various aspects of the flight environment. A flight simulator is categorized into two types, viz. full flight simulators (FFS) and flight simulation training devices (FSTD). Full flight simulator is the replica of a specific type or model and series of an aircraft cockpit, whereas FSTD r …
